Xtant Medical Holdings, Inc. - Common Stock (XTNT)
CUSIP: 98420P308
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 140,036,400
- Total 13F shares
- 11,679,733
- Share change
- +16,932
- Total reported value
- $35,039,000
- Price per share
- $3.00
- Number of holders
- 10
- Value change
- +$50,902
- Number of buys
- 4
- Number of sells
- 2
Quarterly Holders Quick Answers
What is CUSIP 98420P308?
CUSIP 98420P308 identifies XTNT - Xtant Medical Holdings, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 98420P308:
Top shareholders of XTNT - Xtant Medical Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
6.6%
|
9,207,012
|
$28,081,000 | — | 31 Mar 2019 | |
| Park West Asset Management LLC |
13F
|
Company |
0.9%
|
1,258,733
|
$3,839,000 | — | 31 Mar 2019 | |
| Telemetry Investments, L.L.C. |
13F
|
Company |
0.55%
|
768,913
|
$2,345,000 | — | 31 Mar 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.21%
|
289,252
|
$882,000 | — | 31 Mar 2019 | |
| Bruce & Co., Inc. |
13F
|
Company |
—
class O/S missing
|
182,972
|
$558,000 | — | 31 Mar 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.05%
|
67,161
|
$205,000 | — | 31 Mar 2019 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
50,000
|
$153,000 | — | 31 Mar 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
10,824
|
$33,000 | — | 31 Mar 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
9,648
|
$29,000 | — | 31 Mar 2019 | |
| Winslow, Evans & Crocker, Inc. |
13F
|
Company |
0%
|
1,258
|
$4,000 | — | 31 Mar 2019 |
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) as of Q2 2019
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.